[PDF][PDF] Evaluating patient-based outcome measures for use in clinical trials

R Fitzpatrick, C Davey, MJ Buxton, DR Jones - 1998 - figshare.le.ac.uk
NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced
cost of£ 100 for each volume (normally comprising 30–40 titles). The commercial …

[HTML][HTML] The utilisation of health research in policy-making: concepts, examples and methods of assessment

SR Hanney, MA Gonzalez-Block, MJ Buxton… - Health research policy …, 2003 - Springer
The importance of health research utilisation in policy-making, and of understanding the
mechanisms involved, is increasingly recognised. Recent reports calling for more resources …

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

A Briggs, M Sculpher, M Buxton - Health economics, 1994 - Wiley Online Library
Given the increased use of economic evaluation to inform decision making in the health
service, it is particularly important that the research methods used are critically assessed …

Management of post-acute covid-19 in primary care

T Greenhalgh, M Knight, M Buxton, L Husain - bmj, 2020 - bmj.com
Post-acute covid-19 (“long covid”) seems to be a multisystem disease, sometimes occurring
after a relatively mild acute illness. 1 Clinical management requires a whole-patient …

Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial

…, M Bonten, C Bradbury, F Brunkhorst, M Buxton… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019
(COVID-19) is limited. Objective To determine whether hydrocortisone improves outcome for …

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

…, M Bonten, C Bradbury, F Brunkhorst, M Buxton… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

Modelling in ecomomic evaluation: an unavoidable fact of life

MJ Buxton, MF Drummond, BA Van Hout… - Health …, 1997 - Wiley Online Library
The role of modelling in economic evaluation is explored by discussing, with examples, the
uses of models. The expanded use of pragmatic clinical trials as an alternative to models is …

[HTML][HTML] Adaptive randomization of veliparib–carboplatin treatment in breast cancer

HS Rugo, OI Olopade, A DeMichele… - … England Journal of …, 2016 - Mass Medical Soc
Background The genetic and clinical heterogeneity of breast cancer makes the identification
of effective therapies challenging. We designed I-SPY 2, a phase 2, multicenter, adaptively …

[HTML][HTML] Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

C Yau, M Osdoit, M van der Noordaa, S Shad… - The Lancet …, 2022 - thelancet.com
Background Previous studies have independently validated the prognostic relevance of
residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from …

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

…, JI Chacón, J Ferrer-Lozano, R Dyer, M Buxton… - Jama, 2011 - jamanetwork.com
Context Prediction of high probability of survival from standard cancer treatments is
fundamental for individualized cancer treatment strategies. Objective To develop a predictor …